المؤلفون: Cardoso, F, Bartlett, JMS, Slaets, L, van Deurzen, CHM, van Leeuwen-Stok, E, Porter, P, Linderholm, B, Hedenfalk, I, Schroder, C, Martens, J, Bayani, J, van Asperen, C, Murray, M, Hudis, C, Middleton, L, Vermeij, J, Punie, K, Fraser, J, Nowaczyk, M, Rubio, IT, Aebi, S, Kelly, C, Ruddy, KJ, Winer, E, Nilsson, C, Dal Lago, L, Korde, L, Benstead, K, Bogler, O, Goulioti, T, Peric, A, Litiere, S, Aalders, KC, Poncet, C, Tryfonidis, K, Giordano, SH

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology. 29(2):405-417

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:137682396

المؤلفون: Aalders, KC, Touati, N, Tryfonidis, K, Annonay, M, Litiere, S, Bergh, J, Bodmer, A, Cameron, DA, Bonnefoi, HR

المصدر: Breast cancer research and treatment. 169(3):497-505

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:138239003

المؤلفون: Roos MM; Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands. mroos@diakhuis.nl., van Steenhoven JEC; Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands., Aalders KC; Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands., Schreuder K; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands., Burgmans JPJ; Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands., Siesling S; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands., Elias S; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., van Dalen T; Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2019 Feb; Vol. 26 (2), pp. 372-378. Date of Electronic Publication: 2018 Nov 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms/*pathology , Carcinoma, Ductal, Breast/*pathology , Carcinoma, Lobular/*pathology , Neoplasm Recurrence, Local/*pathology , Sentinel Lymph Node/*pathology, Adult ; Aged ; Breast Neoplasms/surgery ; Carcinoma, Ductal, Breast/surgery ; Carcinoma, Lobular/surgery ; False Negative Reactions ; Female ; Follow-Up Studies ; Humans ; Lymph Node Excision ; Middle Aged ; Neoplasm Recurrence, Local/surgery ; Prognosis ; Risk Assessment ; Sentinel Lymph Node/surgery ; Sentinel Lymph Node Biopsy ; Survival Rate

المؤلفون: Aalders KC; Medical Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Kuijer A; Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands; Department of Radiology, University Medical Centre Utrecht, Utrecht, The Netherlands., Straver ME; Department of Surgery, Haaglanden Medical Centre, The Hague, The Netherlands., Slaets L; Department of Statistics, European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Litiere S; Department of Statistics, European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Viale G; Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy., Van't Veer LJ; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Glas AM; Department of Product Development and Support, Agendia, Amsterdam, The Netherlands., Delorenzi M; Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland; Ludwig Center for Cancer Research, University of Lausanne, Epalinges, Switzerland; Department of Oncology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland., van Dalen T; Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands., Tryfonidis K; Medical Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Piccart MJ; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Cardoso F; Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal., Rutgers EJ; Department of Surgery, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, The Netherlands. Electronic address: e.rutgers@nki.nl.

مؤلفون مشاركون: TRANSBIG Consortium and the MINDACT Investigators

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2017 Jul; Vol. 79, pp. 98-105. Date of Electronic Publication: 2017 May 03.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms/*genetics , Genes, Neoplasm/*genetics, Adolescent ; Adult ; Age Distribution ; Aged ; Antineoplastic Agents/therapeutic use ; Breast Neoplasms/pathology ; Breast Neoplasms/therapy ; Disease-Free Survival ; Female ; Gene Expression Profiling/methods ; Gene Expression Regulation, Neoplastic/genetics ; Genome, Human ; Humans ; Lymphatic Metastasis ; Mastectomy/statistics & numerical data ; Middle Aged ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism ; Transcriptome/genetics ; Young Adult

المؤلفون: Aalders KC; Medical Department, European Organisation of Research and Treatment of Cancer (EORTC), Brussels, Belgium. Electronic address: kim.aalders@eortc.be., Tryfonidis K; Medical Department, European Organisation of Research and Treatment of Cancer (EORTC), Brussels, Belgium., Senkus E; Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland., Cardoso F; Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt.

المصدر: Cancer treatment reviews [Cancer Treat Rev] 2017 Feb; Vol. 53, pp. 98-110. Date of Electronic Publication: 2017 Jan 03.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE

مواضيع طبية MeSH: Angiogenesis Inhibitors/*therapeutic use , Breast Neoplasms/*drug therapy, Angiogenesis Inhibitors/adverse effects ; Angiogenesis Inhibitors/economics ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bevacizumab/administration & dosage ; Bevacizumab/therapeutic use ; Breast Neoplasms/blood supply ; Clinical Trials as Topic ; Female ; Humans ; Neoadjuvant Therapy ; Neovascularization, Pathologic/drug therapy ; Treatment Failure

المؤلفون: Aalders KC; Diakonessenhuis Utrecht, Utrecht, The Netherlands. Electronic address: kaalders@diakhuis.nl., van Bommel AC; Leiden University Medical Center, Leiden, The Netherlands., van Dalen T; Diakonessenhuis Utrecht, Utrecht, The Netherlands., Sonke GS; Netherlands Cancer Institute, Amsterdam, The Netherlands., van Diest PJ; University Medical Center Utrecht, Utrecht, The Netherlands., Boersma LJ; University Hospital Maastricht - GROW (MAASTRO), Maastricht, The Netherlands., van der Heiden-van der Loo M; Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2016 Aug; Vol. 63, pp. 118-26. Date of Electronic Publication: 2016 Jun 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Recurrence, Local*/etiology , Neoplasm Recurrence, Local*/pathology, Breast Neoplasms/*pathology , Neoplasms, Second Primary/*etiology, Adult ; Aged ; Antineoplastic Agents/therapeutic use ; Breast Neoplasms/therapy ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Mastectomy, Segmental ; Middle Aged ; Neoplasms, Second Primary/pathology ; Netherlands ; Risk Factors

المؤلفون: Aalders KC; Kim C. Aalders, Emily L. Postma, and Thijs van Dalen, Diakonessenhuis; Margriet van der Heiden-van der Loo and Sabine Siesling, Netherlands Comprehensive Cancer Organization; Paul J. van Diest, University Medical Center Utrecht, Utrecht; Luc J. Strobbe, Canisius Wilhelmina Hospital, Nijmegen; Gabe S. Sonke, Netherlands Cancer Institute, Amsterdam; Liesbeth J. Boersma, University Hospital Maastricht, Maastricht; and Sabine Siesling, University of Twente, Enschede, the Netherlands. kaalders@diakhuis.nl., Postma EL; Kim C. Aalders, Emily L. Postma, and Thijs van Dalen, Diakonessenhuis; Margriet van der Heiden-van der Loo and Sabine Siesling, Netherlands Comprehensive Cancer Organization; Paul J. van Diest, University Medical Center Utrecht, Utrecht; Luc J. Strobbe, Canisius Wilhelmina Hospital, Nijmegen; Gabe S. Sonke, Netherlands Cancer Institute, Amsterdam; Liesbeth J. Boersma, University Hospital Maastricht, Maastricht; and Sabine Siesling, University of Twente, Enschede, the Netherlands., Strobbe LJ; Kim C. Aalders, Emily L. Postma, and Thijs van Dalen, Diakonessenhuis; Margriet van der Heiden-van der Loo and Sabine Siesling, Netherlands Comprehensive Cancer Organization; Paul J. van Diest, University Medical Center Utrecht, Utrecht; Luc J. Strobbe, Canisius Wilhelmina Hospital, Nijmegen; Gabe S. Sonke, Netherlands Cancer Institute, Amsterdam; Liesbeth J. Boersma, University Hospital Maastricht, Maastricht; and Sabine Siesling, University of Twente, Enschede, the Netherlands., van der Heiden-van der Loo M; Kim C. Aalders, Emily L. Postma, and Thijs van Dalen, Diakonessenhuis; Margriet van der Heiden-van der Loo and Sabine Siesling, Netherlands Comprehensive Cancer Organization; Paul J. van Diest, University Medical Center Utrecht, Utrecht; Luc J. Strobbe, Canisius Wilhelmina Hospital, Nijmegen; Gabe S. Sonke, Netherlands Cancer Institute, Amsterdam; Liesbeth J. Boersma, University Hospital Maastricht, Maastricht; and Sabine Siesling, University of Twente, Enschede, the Netherlands., Sonke GS; Kim C. Aalders, Emily L. Postma, and Thijs van Dalen, Diakonessenhuis; Margriet van der Heiden-van der Loo and Sabine Siesling, Netherlands Comprehensive Cancer Organization; Paul J. van Diest, University Medical Center Utrecht, Utrecht; Luc J. Strobbe, Canisius Wilhelmina Hospital, Nijmegen; Gabe S. Sonke, Netherlands Cancer Institute, Amsterdam; Liesbeth J. Boersma, University Hospital Maastricht, Maastricht; and Sabine Siesling, University of Twente, Enschede, the Netherlands., Boersma LJ; Kim C. Aalders, Emily L. Postma, and Thijs van Dalen, Diakonessenhuis; Margriet van der Heiden-van der Loo and Sabine Siesling, Netherlands Comprehensive Cancer Organization; Paul J. van Diest, University Medical Center Utrecht, Utrecht; Luc J. Strobbe, Canisius Wilhelmina Hospital, Nijmegen; Gabe S. Sonke, Netherlands Cancer Institute, Amsterdam; Liesbeth J. Boersma, University Hospital Maastricht, Maastricht; and Sabine Siesling, University of Twente, Enschede, the Netherlands., van Diest PJ; Kim C. Aalders, Emily L. Postma, and Thijs van Dalen, Diakonessenhuis; Margriet van der Heiden-van der Loo and Sabine Siesling, Netherlands Comprehensive Cancer Organization; Paul J. van Diest, University Medical Center Utrecht, Utrecht; Luc J. Strobbe, Canisius Wilhelmina Hospital, Nijmegen; Gabe S. Sonke, Netherlands Cancer Institute, Amsterdam; Liesbeth J. Boersma, University Hospital Maastricht, Maastricht; and Sabine Siesling, University of Twente, Enschede, the Netherlands., Siesling S; Kim C. Aalders, Emily L. Postma, and Thijs van Dalen, Diakonessenhuis; Margriet van der Heiden-van der Loo and Sabine Siesling, Netherlands Comprehensive Cancer Organization; Paul J. van Diest, University Medical Center Utrecht, Utrecht; Luc J. Strobbe, Canisius Wilhelmina Hospital, Nijmegen; Gabe S. Sonke, Netherlands Cancer Institute, Amsterdam; Liesbeth J. Boersma, University Hospital Maastricht, Maastricht; and Sabine Siesling, University of Twente, Enschede, the Netherlands., van Dalen T; Kim C. Aalders, Emily L. Postma, and Thijs van Dalen, Diakonessenhuis; Margriet van der Heiden-van der Loo and Sabine Siesling, Netherlands Comprehensive Cancer Organization; Paul J. van Diest, University Medical Center Utrecht, Utrecht; Luc J. Strobbe, Canisius Wilhelmina Hospital, Nijmegen; Gabe S. Sonke, Netherlands Cancer Institute, Amsterdam; Liesbeth J. Boersma, University Hospital Maastricht, Maastricht; and Sabine Siesling, University of Twente, Enschede, the Netherlands.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2016 Jun 20; Vol. 34 (18), pp. 2107-14. Date of Electronic Publication: 2016 Mar 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms/*pathology , Neoplasm Recurrence, Local/*epidemiology, Adult ; Breast Neoplasms/chemistry ; Female ; Humans ; Neoplasm Staging ; Receptor, ErbB-2/analysis ; Receptors, Estrogen/analysis

المؤلفون: Madsen EV; Department of Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Aalders KC; Department of Surgery, Diakonessenhuis, Utrecht, The Netherlands., van der Heiden-van der Loo M; Comprehensive Cancer Institute, Amsterdam, The Netherlands., Gobardhan PD; Department of Surgery, Amphia Hospital, Breda, The Netherlands., van Oort PM; Department of Surgery, Diakonessenhuis, Utrecht, The Netherlands., van der Ent FW; Department of Surgery, Orbis Medical Center, Sittard, The Netherlands., Rutgers EJ; Department of Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Valdés Olmes RA; Department of Nuclear Medicine, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Elias SG; Department of Clinical Epidemiology, University Medical Center Utrecht, Utrecht, The Netherlands., van Dalen T; Department of Surgery, Diakonessenhuis, Utrecht, The Netherlands. tvdalen@diakhuis.nl.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2015 Dec; Vol. 22 (13), pp. 4254-62. Date of Electronic Publication: 2015 Mar 26.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Sentinel Lymph Node Biopsy*, Breast Neoplasms/*pathology , Carcinoma, Ductal, Breast/*secondary, Adult ; Aged ; Aged, 80 and over ; Axilla ; Breast Neoplasms/diagnostic imaging ; Breast Neoplasms/mortality ; Breast Neoplasms/surgery ; Carcinoma, Ductal, Breast/diagnostic imaging ; Carcinoma, Ductal, Breast/mortality ; Carcinoma, Ductal, Breast/surgery ; Cohort Studies ; Female ; Follow-Up Studies ; Humans ; Lymphatic Metastasis ; Middle Aged ; Neoplasm Grading ; Neoplasm Invasiveness ; Neoplasm Staging ; Prognosis ; Radionuclide Imaging ; Survival Rate ; Young Adult